The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Alector, Inc(NASDAQ:ALEC) 
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Park...
Website: http://alector.com
Founded: 2013
Full Time Employees: 162
Sector: Healthcare
Industry: Biotechnology
Alector Days Payable Outstanding ttm (DPO)
Alector Days Receivable Outstanding ttm (DSO)
Alector Op Cashflow Per Share ttm
Alector Free Cashflow Per Share ttm
Alector Cash Per Share ttm
Alector P/S ratio ttm
Alector (GAAP) P/E ratio ttm
Alector P/B ratio ttm
No extra charts and metrics for this ticker.